A team headed by the MHH is researching new therapies for chronically inflamed bile ducts.

Observational study shows significant decline in systemic inflammation levels after treatment with ETI medication.

MHH researchers have found biomarkers that predict which patients will benefit from treatment with checkpoint inhibitors.

At the MHH, a Fulbright scholarship holder is combining engineering technology and immunology to improve the treatment of wounds.

Thanks to the technology, more donor kidneys can be transplanted.

MHH nephrologists find cells that provide information about the function of the kidney transplant after rejection.

Li-Fraumeni syndrome: study provides new approaches for personalized care for those affected

MHH researchers discover sugar structures on kidney cells that can predict the response to treatment with immune checkpoint inhibitors.

Dr. Katja Dinkelborg, PhD is a physician researching the hepatitis E virus

MHH scientists are investigating how pro-inflammatory cytokines intervene in the metabolism of muscles and actively remodel them.